Determining if disease management saves money: an introduction to meta-analysis.
Disease management (DM) programmes have long been promoted as a major medical cost-saving mechanism, even though the scant research that exists on the topic has provided conflicting results. In a 2004 literature review, the Congressional Budget Office stated that 'there is insufficient evidence to conclude that disease management programs can generally reduce the overall cost of health care services'. To address this question more accurately, a meta-analysis was warranted. Meta-analysis is the quantitative technique used to pool the results of many studies on the same topic and summarize them statistically. This method is also quite suitable for individual DM firms to assess whether their programmes are effective at the aggregate level. This paper describes the elements of a rigorous meta-analytic process and discusses potential biases. A hypothetical DM organization is then evaluated with a specific emphasis on medical cost-savings, simulating a case in which different populations are served, evaluation methodologies are employed, and diseases are managed.
Linden
Ariel
A
Linden Consulting Group, and Oregon Health and Science University, School of Medicine and School of Nursing, Portland, OR, USA. alinden@lindenconsulting.org
Adams
John L
JL
D003363:Cost Control; D019468:Disease Management; D006801:Humans; D015201:Meta-Analysis as Topic; D014481:United States